A Study to Compare if the Uptake of Ticagrelor in the Body Differs When Different Tablets Are Administered

Summary

To evaluate the relative bioavailability of ticagrelor for the different formulations. A randomized cross-over design has been chosen to minimize the effects of between-subject variability and any period effects on the overall results.

Timeline

Start

2017-05-12

Primary completion

2017-07-24

Completion

2017-07-24

Publications

• Niazi M, Wissmar J, Berggren AR, Karlsson C, Johanson P. Development Strategy and Relative Bioavailability of a Pediatric Tablet Formulation of Ticagrelor. Clin Drug Investig. 2019 Aug;39(8):765-773. doi: 10.1007/s40261-019-00800-w.

Drugs

Indications